415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis

BACKGROUND: Isavuconazole (ISA) is a novel triazole antifungal approved for treating invasive aspergillosis and mucormycosis. While ISA is increasingly used for prophylaxis in hematologic malignancy patients when other azoles are contraindicated, there are currently limited data on breakthrough inva...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: DeVoe, Catherine, Fung, Monica, Schwartz, Brian, Doernberg, Sarah B, Lo, Mimi, Graff, Larissa, Tan, Marisela, Logan, Aaron, Babik, Jennifer, Chin-Hong, Peter
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253539/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.426
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items